Search clinical trials for: Metformin and nizatidine

Total 270321 results

GlaxoSmithKline

Completed

Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.

Diabetes Mellitus, Type 2

Spain, Germany, France, Austria, Italy
K. Marcinkowski University of Medical Sciences

Completed

Metformin in Gestational Diabetes Mellitus (MetGDM)

Insulin Resistance | Diabetes, Gestational

Poland
University of Oulu
University of Turku; University of Helsinki; Tampere University; University of...

Completed

The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)

Toxemia | Polycystic Ovary Syndrome | Infertility | Miscarriage | Gestational Diabetes

Finland
AstraZeneca

Completed

The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

Healthy Subjects in Fasted and Fed State

Brazil
University of Utah

Active, not recruiting

Role of Metformin on Muscle Health of Older Adults

Insulin Resistance | Muscle Atrophy

United States
Merck Sharp & Dohme LLC

Completed

A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)

Type 2 Diabetes Mellitus
Caio Eduardo Gonçalves Reis
University of Brasilia; Conselho Nacional de Desenvolvimento Científico e Tecnológico and other collaborators

Completed

Metabolic Effects of a Caloric Restriction High/Low Glycemic Index Diet Plus Metformin in Overweight/Obese Subjects

Obesity

Brazil
Rutgers University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome

Metabolic Syndrome

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects

Healthy

Germany
Taipei Medical University WanFang Hospital

Terminated

The Combination Effect of Statin Plus Metformin on Relapse-free

Hepatocellular Carcinoma

Taiwan
JW Pharmaceutical

Completed

Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.

Healthy

Korea, Republic of
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Activity and Metformin Intervention in Obese Adolescents (REACH)

Obesity | Type 2 Diabetes

Canada
Services Hospital, Lahore

Completed

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

Diabetes, Type 2

Pakistan
Boehringer Ingelheim

Completed

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Diabetes Mellitus, Type 2

Germany
University of Pennsylvania
Abbott

Completed

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

Metabolic Syndrome x

United States
Shanghai 10th People's Hospital

Not yet recruiting

SGLT2 Inhibitors in Treating Patients With PCOS

Polycystic Ovary Syndrome
LG Chem

Completed

BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

Healthy Male Volunteers

Korea, Republic of
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery

Breast Cancer

United States
University Health Network, Toronto

Active, not recruiting

The Metformin Active Surveillance Trial (MAST) Study (MAST)

Prostate Cancer

Canada
Ain Shams University

Completed

Effect of Metformin in Children With Type 1 Diabetes

Effect of Change in T1DM Glycemic Control

Egypt
Hospital Civil de Guadalajara

Unknown

Metformin and Systemic Inflammation in HIV (Metfo)

PreDiabetes | HIV-1-infection

Mexico
University of Dundee

Completed

MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease (MET-REMODEL)

Coronary Artery Disease | Insulin Resistance | PreDiabetes | Left Ventricular Hypertrophy

United Kingdom
Postgraduate Institute of Medical Education and...
Council of Scientific and Industrial Research, India

Withdrawn

Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients

Type 2 Diabetes

India
Sanofi

Completed

Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients

Type 2 Diabetes Mellitus

Germany
University of Leipzig

Completed

Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease (KFO)

Obesity | Impaired Glucose Tolerance | Stable Coronary Artery Disease

Germany
Virginia Commonwealth University

Terminated

Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome | PCOS | Insulin Sensitivity

United States
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Withdrawn

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

Diabetes Mellitus Type 2
Laboratorios Silanes S.A. de C.V.

Completed

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients (DMMET2)

Diabetes Type 2

Mexico
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

Healthy

United States
Wellstat Therapeutics

Completed

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Type 2 Diabetes Mellitus

United States
University of Southern Denmark

Completed

Inter- and Intra-individual Variations in Metformin Pharmacokinetics - The Importance of Genes and Drug Interactions

Metformin | Organic Cation Transporter 1 | Codeine

Denmark
University of Alabama at Birmingham
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.

Pre-diabetes

United States
Pennington Biomedical Research Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea (MET-OSA)

Sleep Apnea, Obstructive

United States
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation

Completed

Metformin Therapy for Overweight Adolescents With Type 1 Diabetes

Type 1 Diabetes

United States
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Completed

Effect of Metformin and Probiotics on Gut Microbiome in Healthy Subjects

Healthy

China
Kristian Karstoft
University of Copenhagen

Completed

The Interaction Between Metformin and Physical Training

Diabetes Mellitus, Type 2 | Impaired Glucose Tolerance

Denmark
Beth Israel Medical Center
St. Luke's-Roosevelt Hospital Center

Terminated

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) (METRO)

Nonsquamous Nonsmall Cell Neoplasm of Lung | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB/IV

United States
GlaxoSmithKline

Completed

Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects

Diabetes Mellitus, Type 2

United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
GlaxoSmithKline

Completed

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Diabetes Mellitus, Type 2

United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
Novo Nordisk A/S

Completed

Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Malaysia, Thailand, China, Philippines
Merck Sharp & Dohme LLC

Terminated

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

Diabetes Mellitus, Type 2
Jack Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Metformin to Treat Obesity in Children With Insulin Resistance

Obesity | Hyperinsulinemia

United States
LG Life Sciences

Completed

Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

Type 2 Diabetes Mellitus

Korea, Republic of
Rajavithi Hospital

Completed

Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells

Metformin | CA Endometrium

Thailand
Sun Yat-sen University

Not yet recruiting

The Effect of Metformin in Patients With Newly Diagnosed mHSPC

Metastatic Prostate Cancer

China
University of Pennsylvania
Pennsylvania Department of Health

Completed

Effects of Metformin During Nicotine Withdrawal (MEP)

Smoking | HIV-1-infection

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage I-III Pancreatic Cancer

United States
Tianjin Medical University Cancer Institute and...
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients (SMART)

Non Small Cell Lung Cancer

China
University of Exeter
University of Bristol; University of Dundee

Withdrawn

Autoimmune Diabetes Accelerator Prevention Trial (adAPT)

Prediabetic State

United Kingdom

Search clinical trials for: Metformin and nizatidine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations